Decisions on Drug Safety The drug rosiglitazone (Avandia) is effective in
lowering blood glucose levels in patients with type 2 diabetes, but a few
years after rosiglitazone came into widespread use, it seemed that using the
drug came with an increased risk of heart attack. In response, the U.S. Food
and Drug Administration (FDA) severely restricted the conditions under which
it could be prescribed. Two years later, after additional studies had been
completed, the FDA lifted the restrictions, and today rosiglitazone is
available by prescription in the United States, with no special limitations.
Many other countries ban it completely. If it were your responsibility to
decide whether this drug should remain on the market (labeled with suitable
warnings about its side effects) or should be withdrawn from the market
altogether, what factors would you weigh in making your decision?